KIRSKE DAVID - Insider Non-Derivative Transactions at CTI BIOPHARMA CORP (CTIC) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 26, 2023, KIRSKE DAVID's relationship to CTI BIOPHARMA CORP (CTIC) is Officer (EVP, Chief Financial Officer), and currently has 0 shares of common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CTIC insiders.

Data Source: SEC.
KIRSKE DAVID - Insider Non-Derivative Transactions of CTIC common stock
KIRSKE DAVID - Insider Non-Derivative Transactions at CTIC
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 27, 2023 U -- (Common Stock) 17547 9.1 0
Jan 4, 2023 Sell -- (common stock) 27021 6.01 17127
Jan 4, 2023 M -- (common stock) 27021 0.95 44148
Dec 31, 2022 Sell -- (common stock) 1047 6.01 17127
Dec 31, 2022 Acquisition -- (common stock) 214 5.11 17127
Dec 31, 2022 Sell -- (common stock) 12000 6 17127
Dec 31, 2022 Sell -- (common stock) 800 6.01 17127
Dec 31, 2022 M -- (common stock) 800 0.95 17927
Dec 31, 2022 M -- (common stock) 1047 0.95 18174
Dec 31, 2022 M -- (common stock) 12000 0.95 29127
Dec 30, 2022 Sell -- (common stock) 13174 6 16913
Dec 30, 2022 M -- (common stock) 13174 0.95 30087